Cedar Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AWA
Cedar Wealth Management's AMGN Position: Q4 2022 in Review
Cedar Wealth Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 498 shares — an estimated $112K sold.
Cedar Wealth Management first reported a position in AMGN in Q3 2019 and held it in 13 quarters. The position peaked at $533K in Q1 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- Cedar Wealth Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
- Cedar Wealth Management sold 498 Amgen shares in Q4 2022, an estimated $112K.
- Cedar Wealth Management first reported a position in Amgen in Q3 2019 and held it in 13 quarters.
- Cedar Wealth Management's Amgen position peaked at $533K in Q1 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on Cedar Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.